Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, Ephrat, Wasco, Wilma, Poorkaj, Parvoneh, Romano, Donna M., Oshima, Junko, Pettingell, Warren H., Yu, Chang-en, Jondro, Paul D. +11 more·1995·Science
DOI 10.1126/science.7638622

Cited by (1,015)

Items 601–700 of 1,015

  1. Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains
    Gregory A. Elder, Nikolaos Tezapsidis, Janet E. Carter, Junichi Shioi, Constantin Bouras, H.‐C. Li, Jane M. Johnston, Spiros Efthimiopoulos, Victor L. Friedrich, Nikolaos K. R K Robakis · 1996 · Journal of Neuroscience Research
  2. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
    Knuesel, Irene · 2010 · Progress in Neurobiology
  3. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
    Pritchard, Susanne M., Dolan, Philip J., Vitkus, Alisa, Johnson, Gail V.W. · 2011 · Journal of Cellular and Molecular Medicine
  4. Akt/GSK3β serine/threonine kinases: evidence for a signalling pathway mediated by familial Alzheimer's disease mutations
    John W. Ryder, Su Yuan, Binhui Ni · 2003 · Cellular Signalling
  5. The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores
    Giancarlo Zatti, Roberta Ghidoni, Laura Barbiero, Giuliano Gb. Binetti, Tullio Pozzan, Cristina Fasolato, Paola Pizzo · 2004 · Neurobiology of Disease
  6. Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
    Logan Brase, Shih‐Feng You, Ricardo D’Oliveira Albanus, Jorge L. Del‐Aguila, Yaoyi Dai, Brenna C. Novotny, Carolina Soriano‐Tárraga, Taitea Dykstra, María Victoria Fernández, John Budde et al. · 2023 · Nature Communications
  7. β‐Amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury
    Karen J. Horsburgh, G. M. Cole, F. Yang, Mary J. Savage, Barry Greenberg, Stephen M. Gentleman, David Ian Graham, James A. R. Nicoll · 2000 · Neuropathology and Applied Neurobiology
  8. Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
    Antonino Cattaneo, Pietro Calissano · 2012 · Molecular Neurobiology
  9. Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease
    Hassan Bukhari, Annika Glotzbach, Katharina Kolbe, Gregor Leonhardt, Christina Loosse, Thorsten Müller · 2017 · Progress in neurobiology
  10. Multipoint Oligogenic Analysis of Age-at-Onset Data with Applications to Alzheimer Disease Pedigrees
    E. Warwick Daw, Simon Charles Heath, Ellen M. Wijsman · 1999 · The American Journal of Human Genetics
  11. The genetics of late-onset Alzheimerʼs disease
    Amanda Myers, Alison Goate · 2001 · Current Opinion in Neurology
  12. A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease
    Lovell, Mark A. · 2009 · Journal of Alzheimer s Disease
  13. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators
    Frédéric Checler, Bruno Vincent · 2002 · Trends in Neurosciences
  14. Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
    Lambert, Jean-Charles, Ramirez, Alfredo, Grenier-Boley, Benjamin, Bellenguez, Céline · 2023 · Molecular Psychiatry
  15. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans
    Chenyin Wang, Valeria Saar, Ka Lai Leung, Liang Chen, Garry Wong · 2017 · Neurobiology of Disease
  16. Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice
    Lara Ordóñez‐Gutiérrez, Francesca Re, Erika Bereczki, Enikő Ioja, Maria Gregori, Alina J. Andersen, Marta Antón, Seyed Moein Moghimi, Jin-Jing Pei, Massimo Masserini et al. · 2014 · Nanomedicine Nanotechnology Biology and Medicine
  17. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility
    Jessie Theuns · 2000 · Human Molecular Genetics
  18. Mitochondrial Abnormalities in Alzheimer’s Disease
    Silva, Diana F., Selfridge, J. Eva, Lu, Jianghua, E, Lezi, Cardoso, Sandra M., Swerdlow, Russell H. · 2012 · Advances in Pharmacology
  19. Mutant Presenilin 2 Transgenic Mice
    Naoya Sawamura, Maho Morishima‐Kawashima, Hatsue Waki, Kimio Kobayashi, Takashi Kuramochi, Matthew P. Frosch, Kai Ding, Mamoru Ito, Tae‐Wan Kim, Rudolph E. Tanzi et al. · 2000 · Journal of Biological Chemistry
  20. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity
    Robin L. Cotter, W. J. Burke, Vince Salazar Thomas, JANE F. POTTER, Jialin Zheng, Howard Eliot Gendelman · 1999 · Journal of Leukocyte Biology
  21. Free radical theory of aging: Alzheimer’s disease pathogenesis
    Denham Harman · 1995 · AGE
  22. Genetic factors in Alzheimer's disease: A review of recent advances
    Ephrat Levy‐Lahad, Thomas D. Bird · 1996 · Annals of Neurology
  23. Novel mutations and repeated findings of mutations in familial Alzheimer disease
    Ulrich Finckh, Christian Kuschel, Maria C. Anagnostouli, Efstratios Patsouris, George V. Pantes, Stylianos D. Gatzonis, Elisabeth N. Kapaki, Panagiota Davaki, Katrin Lamszus, Dimitrios Stavrou et al. · 2005 · Neurogenetics
  24. Variant Alzheimer Disease With Spastic paraparesis: Neuropathological phenotype
    Auli Verkkoniemi, Hannu Kalimo, Anders E. Paetau, Mirja Somer, Takeshi Iwatsubo, John Hardy, Matti Haltia · 2001 · Journal of Neuropathology & Experimental Neurology
  25. Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease
    Ishii, Kazuhiro, Tamaoka, Akira, Mizusawa, Hidehiro, Shoji, Shin-ichi, Ohtake, Toshiyuki, Fraser, Peter E, Takahashi, Hitoshi, Tsuji, Shoji, Gearing, Marla, Mizutani, Toshio et al. · 1997 · Brain Research
  26. Building γ-secretase – the bits and pieces
    Dragana Spasić, Wim G. Annaert · 2008 · Journal of Cell Science
  27. Endogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments
    Lah, James J., Levey, Allan I. · 2000 · Molecular and Cellular Neuroscience
  28. Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase Inhibitor
    Dirk Beher, Jonathan D.J. Wrigley, Alan J. Nadin, Genevieve M. Evin, Colin Louis Masters, Timothy Harrison, José L. Castro, Mark S. Shearman · 2001 · Journal of Biological Chemistry
  29. A 1.1-Mb Transcript Map of the Hereditary Hemochromatosis Locus
    David A. Ruddy, Gregory S. Kronmal, Vince Lee, Gabriel A. Mintier, Leah Quintana, Rodolfo Domingo, Nicole C. Meyer, Alivelu Irrinki, Erin E. McClelland, A. Fullan et al. · 1997 · Genome Research
  30. Presenilin-1 Mutations in Alzheimer's Disease: An Update on Genotype-Phenotype Relationships
    Andrew J. Larner · 2013 · Journal of Alzheimer s Disease
  31. Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous System
    Berislav V. Zloković, Michael L.J. Apuzzo · 1997 · Neurosurgery
  32. The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk
    Jialing Fan, Wuhai Tao, Xin Li, He Li, Junying Zhang, Dongfeng Wei, Yaojing Chen, Zhanjun Zhang · 2019 · International Journal of Molecular Sciences
  33. Generation of C‐terminally truncated amyloid‐β peptides is dependent on γ‐secretase activity
    Dirk Beher, Jonathan D.J. Wrigley, Andrew P. Owens, Mark S. Shearman · 2002 · Journal of Neurochemistry
  34. Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
    Hongwen He, Weiguo Dong, Fang Ping Huang · 2010 · Current Neuropharmacology
  35. γ-Secretase as a Target for Alzheimer’s Disease
    Michael S. Wolfe · 2012 · Advances in pharmacology
  36. γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
    Xuemin Xu · 2009 · Journal of Alzheimer s Disease
  37. β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease
    Niels Andreasen, Kaj Blennow · 2002 · Peptides
  38. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
    Susan Iivonen, Elizabeth H. Corder, Maarit Lehtovirta, Seppo Helisalmi, A. Mannermaa, Saila Vepsäläinen, Tuomo Hänninen, Hilkka S. Soininen, Mikko O. Hiltunen · 2004 · Neurology
  39. Drosophila presenilinIs Required for Neuronal Differentiation and Affects Notch Subcellular Localization and Signaling
    Yiquan Guo, Izhar Livne‐Bar, Lily Zhou, Gabrielle L. Boulianne · 1999 · Journal of Neuroscience
  40. GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus
    MaSalomé Sirerol‐Piquer, Pilar Gómez‐Ramos, Félix Hernández, Mar Pérez, María A. Morán, Almudena Fuster-Matanzo, José J. Lucas, Jesús Ávila, José Manuel García‐Verdugo · 2010 · Hippocampus
  41. Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
    Bo Su, Xinglong Wang, David Bonda, George L. Perry, Mark A. Smith, Xiongwei Zhu · 2010 · Molecular Neurobiology
  42. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease
    Lesley Jones, Denise H. Harold, Julie H. Williams · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  43. Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease
    Tsuyoshi Hamaguchi, Kenjiro Ono, Masahito Yamada · 2006 · Cellular and Molecular Life Sciences
  44. Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel- 12 and hop- 1 in Notch-pathway signaling
    Bethany Westlund, Dianne Parry, Ralph Clover, Michael Basson, Carl D. Johnson · 1999 · Proceedings of the National Academy of Sciences
  45. The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
    Marcus O.W. Grimm, Valerie C. Zimmer, Johannes Lehmann, Heike S. Grimm, Tobias Hartmann · 2013 · BioMed Research International
  46. Proteomics in animal models of Alzheimer's and Parkinson's diseases
    Renã A. S. Robinson, Joshua B. Owen, David Allan Butterfield · 2008 · Ageing Research Reviews
  47. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein — initial observations
    Margarita Diez, Jari Koıstınaho, K Kahn, Dora Games, Tomas G. M. Hökfelt · 2000 · Neuroscience
  48. The C-terminal Tail of Presenilin Regulates Omi/HtrA2 Protease Activity
    Sanjeev Gupta, Rajesh Singh, Pinaki Datta, ZhiJia Zhang, Christopher R. Orr, Zhixian Lu, Garrett C DuBois, Antonis S. Zervos, Miriam H. Meisler, Srinivasa Murty Srinivasula et al. · 2004 · Journal of Biological Chemistry
  49. Signal Peptide Peptidase Forms a Homodimer That Is Labeled by an Active Site-directed γ-Secretase Inhibitor
    Andrew C. Nyborg, Anna Y. Kornilova, Karen R. Jansen, Thomas B. Ladd, Michael S. Wolfe, Todd Eliot Golde · 2004 · Journal of Biological Chemistry
  50. Alzheimer Disease
    Caselli, Richard J., Beach, Thomas G., Knopman, David S., Graff-Radford, Neill R. · 2017 · Mayo Clinic Proceedings
  51. The Relationship between Amyloid and Tau
    Hardy, John · 2003 · Journal of Molecular Neuroscience
  52. Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
    Kasper P. Kepp · 2016 · Journal of Alzheimer s Disease
  53. Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis
    Shirley E. Poduslo, Rong Huang, J. Huang, S. Smith · 2008 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  54. Fine mapping of the -T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
    Nilufer Ertekin-Taner · 2003 · Human Molecular Genetics
  55. APOE and other loci affect age‐at‐onset in Alzheimer's disease families with PS2 mutation
    Wijsman, Ellen M., Daw, E. Warwick, Yu, Xuesong, Steinbart, Ellen J., Nochlin, David, Bird, Thomas D., Schellenberg, Gerard D. · 2005 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  56. N-butylidenephthalide Attenuates Alzheimer's Disease-Like Cytopathy in Down Syndrome Induced Pluripotent Stem Cell-Derived Neurons
    Chia‐Yu Chang, Sheng-Mei Chen, Huai-En Lu, Syu-Ming Lai, Ping‐Shan Lai, Po-Wen Shen, Pei-Ying Chen, Ching-I Shen, Horng‐Jyh Harn, Shinn‐Zong Lin et al. · 2015 · Scientific Reports
  57. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia
    Marta Giacomello, Laura Barbiero, Giancarlo Zatti, Rosanna Squitti, Giuliano Gb. Binetti, Tullio Pozzan, Cristina Fasolato, Roberta Ghidoni, Paola Pizzo · 2005 · Neurobiology of Disease
  58. Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
    Katriona L. Hole, Robert J. Williams · 2020 · Brain Plasticity
  59. Genetic heterogeneity of Alzheimer's disease: Complexity and advances
    Jean‐Charles Lambert, Philippe Amouyel · 2007 · Psychoneuroendocrinology
  60. Molecular Dissection of Domains in Mutant Presenilin 2 That Mediate Overproduction of Amyloidogenic Forms of Amyloid β Peptides
    Taisuke Tomita, Shinya Tokuhiro, Tadafumi Hashimoto, Keiko Aiba, Takaomi C. Saido, Kei Maruyama, Takeshi Iwatsubo · 1998 · Journal of Biological Chemistry
  61. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
    Claudio A. Soto · 1999 · Journal of Molecular Medicine
  62. Early-Onset Alzheimer Disease in Families With Late-Onset Alzheimer Disease: A Potential Important Subtype of Familial Alzheimer Disease
    Brickell, Kiri L., Steinbart, Ellen J., Rumbaugh, Malia, Payami, Haydeh, Schellenberg, Gerard D., Van Deerlin, Vivianna, Yuan, Wuxing, Bird, Thomas D. · 2006 · Archives of Neurology
  63. Cholesterol and Myelin
    Jackson Snipes, G., Suter, Ueli · 1997 · Subcellular Biochemistry
  64. Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
    Szyf, Moshe · 2015 · European Neuropsychopharmacology
  65. Function and Dysfunction of the Presenilins
    Sisodia, Sangram S., Kim, Seong H., Thinakaran, Gopal · 1999 · The American Journal of Human Genetics
  66. Cerebral organoids derived from patients with Alzheimer’s disease with PSEN1/2 mutations have defective tissue patterning and altered development
    Tereza Váňová, Jiří Sedmík, Jan Raška, Kateřina Amruz Černá, Petr Tauš, Veronika Pospisilova, Markéta Nezvedová, Veronika Fedorová, Sona Kadakova, Hana Klímová et al. · 2023 · Cell Reports
  67. Integrated Whole Transcriptome and DNA Methylation Analysis Identifies Gene Networks Specific to Late-Onset Alzheimer's Disease
    Crystal Humphries, Martin A. Kohli, Lubov Nathanson, Patrice L. Whitehead, Gary W. Beecham, Eden R. Martin, Deborah C. Mash, Margaret Ann Pericak‐Vance, John R. Gilbert · 2015 · Journal of Alzheimer s Disease
  68. Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
    Agueda A. Rostagno, Janice L. Holton, Tammaryn Lashley, Tamás Révész, Jorge A. Ghiso · 2009 · Cellular and Molecular Life Sciences
  69. The overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 variants influences TRPC6-enhanced Ca2+ entry into HEK293 cells
    Christian B. Lessard, Marc P. Lussier, Sylvie Cayouette, Geneviève Bourque, Guylain Boulay · 2004 · Cellular Signalling
  70. Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology
    José A. Santiago, Virginie Bottero, Judith A. Potashkin · 2017 · Frontiers in Aging Neuroscience
  71. Tryptophan hydroxylase mRNAs analysis by RT-PCR: Preliminary report on the effect of noradrenaline in the neonatal rat pineal gland
    R. Besan�on, Ariel Reboul, Bruno Claustrat, Anne Jouvet, Marie-Fran�oise Belin, Michelle Fèvre‐Montange · 1997 · Journal of Neuroscience Research
  72. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease
    Allen D. Roses · 1997 · Neurogenetics
  73. Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N<sup>141</sup>I)
    Nochlin, David, Bird, Thomas D., Nemens, Ellen J., Ball, Melvyn J., Sumi, S. Mark · 1998 · Annals of Neurology
  74. Vascular pathology: Cause or effect in Alzheimer disease?
    Sergio Rius‐Pérez, Ana M. Tormos, Salvador Pérez, Raquel Taléns‐Visconti · 2017 · Neurología (English Edition)
  75. Genetic Markers of Alzheimer’s Disease
    Matea Nikolac Perković, Nela Pivac · 2019 · Advances in experimental medicine and biology
  76. Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10
    Xueying Sharon Liang, Michael A. Slifer, Eden R. Martin, Nathalie C. Schnetz‐Boutaud, Jackie Bartlett, Brent Anderson, Stephan L. Zuchner, Harry E. Gwirtsman, John R. Gilbert, Margaret Ann Pericak‐Vance et al. · 2008 · Human Mutation
  77. The recycling endosome and its role in neurological disorders
    Xueyi Li, Marian DiFiglia · 2011 · Progress in Neurobiology
  78. A novel presenilin‐1 mutation: Increased β‐amyloid and neurofibrillary changes
    Teresa Gómez‐Isla, Wilma Wasco, Warren P. Pettingell, Sarada Gurubhagavatula, Stephen D. Schmidt, P. D. Jondro, Megan J. McNamara, L. Rodes, Tatiana Di-Blasi, Whitfield B. Growdon et al. · 1997 · Annals of Neurology
  79. Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
    Valentina Echeverrı́a, A. Claudio Cuello · 2002 · Molecular Neurobiology
  80. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.
    Gail Pairitz Jarvik, Eric Berg Larson, Katrina A.B. Goddard, Gerard D. Schellenberg, Ellen M. Wijsman · 1996 · PubMed Central
  81. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation
    Dermaut, B. · 2001 · Brain
  82. Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease
    Dingding Mo, Xinping Li, Carsten Alexander Raabe, Timofey S. Rozhdestvensky, Boris V. Skryabin, Juergen Brosius · 2020 · Cells
  83. Genetic variation in APOE cluster region and Alzheimer's disease risk
    Sebastián Cervantes, Lluı́s Samaranch, Jose Manuel Vidal-Taboada, Isabel Lamet, Maria Jesus Bullido, Ana Frank, Francisco Coria, Albert Lleó, Jordi Clarimón, Elena Lorenzo et al. · 2011 · Neurobiology of Aging
  84. Genealogy, expression, and molecular mechanisms in apoptosis
    Zodwa Dlamini, Zukile Mbita, Makhosazana Zungu · 2004 · Pharmacology & Therapeutics
  85. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study
    Robert A. Sweet, David Alan Bennett, Neill R. Graff‐Radford, Richard P Mayeux · 2010 · Brain
  86. The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
    Yun Freudenberg‐Hua, Wentian Li, Peter Davies · 2018 · Frontiers in Medicine
  87. The genetic basis of cognition
    Jonathan Flint · 1999 · Brain
  88. Evidence That Intramolecular Associations between Presenilin Domains Are Obligatory for Endoproteolytic Processing
    Carlos A. Saura, Taisuke Tomita, Frances Davenport, Christie L. Harris, Takeshi Iwatsubo, Gopal Thinakaran · 1999 · Journal of Biological Chemistry
  89. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models
    P. Hemachandra Reddy, Shannon K. McWeeney · 2005 · Neurobiology of Aging
  90. First Evidence to Show the Topological Change of DNA from B-DNA to Z-DNA Conformation in the Hippocampus of Alzheimer's Brain
    Anitha Suram, Jagannatha K.S. Rao, Latha K. S., M. A. Viswamitra · 2002 · NeuroMolecular Medicine
  91. Semagacestat Is a Pseudo-Inhibitor of γ-Secretase
    Shinji Tagami, Kanta Yanagida, Takashi S Kodama, Mako Takami, Naoki Mizuta, Hiroshi Ōyama, Kouhei Nishitomi, Yu-wen Chiu, Toru Okamoto, Takeshi Ikeuchi et al. · 2017 · Cell Reports
  92. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease
    Peter Holmans, Marian L. Hamshere, Paul Hollingworth, Frances J. Rice, Nigel Tunstall, Sue Jones, Pamela J. Moore, Fabienne Wavrant DeVriéze, Amanda Myers, Richard Crook et al. · 2005 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  93. The Alzheimer diseases
    Allen D. Roses · 1996 · Current Opinion in Neurobiology
  94. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes
    Hernandez, Dena, Sugaya, Kiminobu, Qu, Tingyu, McGowan, Eileen, Duff, Karen, McKinney, Michael · 2001 · Neuroreport
  95. Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation
    Masato Hasegawa · 2016 · Biomolecules
  96. SEL‐10 interacts with presenilin 1, facilitates its ubiquitination, and alters A‐beta peptide production
    Jinhe Li, Adele M. Pauley, Rick L. Myers, Rongqing Shuang, John R. Brashler, Riqiang Yan, Allen E. Buhl, Cara Ruble, Mark E. Gurney · 2002 · Journal of Neurochemistry
  97. A Role for Presenilin 1 in Regulating the Delivery of Amyloid Precursor Protein to the Cell Surface
    Jae Yoon Leem, Carlos A. Saura, Claus U. Pietrzik, John C. Christianson, Christian Wanamaker, LaShaunda T. King, Margaret Veselits, Taisuke Tomita, Laura Gasparini, Takeshi Iwatsubo et al. · 2002 · Neurobiology of Disease
  98. Genetics of Psychosis in Alzheimer's Disease: A Review
    Mary Ann A. DeMichele‐Sweet, Robert A. Sweet · 2010 · Journal of Alzheimer s Disease
  99. Genetic risk factors in Alzheimer's disease.
    Louise A. Tilley, Kevin Morgan, Noor A Kalsheker · 1998 · Molecular Pathology
  100. Genetic Association of Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) With Alzheimer's Disease
    Zuomin Chen, Micah S. Simmons, Rodney T. Perry, Howard W. Wiener, Lindy E. Harrell, Rodney C.P. Go · 2007 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics